Anti-D immunoglobulin must be given to a mother of O-negative blood group with a baby of O-positive blood group within how many hours?
What is the most common cause of maternal mortality?
A postpartum woman has acute puerperal mastitis. Which of the following statements is true?
Without breast feeding, the first menses usually begins how many weeks after delivery?
Maternal mortality is maximum in which period?
A female presents with significant blood loss due to postpartum hemorrhage (PPH). What is the normal shock index (Heart Rate / Systolic Blood Pressure)?
Atonic postpartum hemorrhage occurs in all the following except:
What is the recommended dose of Carbetocin for postpartum hemorrhage?
What is the rate of uterine involution?
Which of the following is NOT a cause of atonic postpartum hemorrhage?
Explanation: **Explanation:** The correct answer is **72 hours**. This question addresses the prevention of Rh isoimmunization, a critical concept in obstetric care. **1. Why 72 hours is correct:** Anti-D immunoglobulin (RhIg) is administered to an Rh-negative mother who delivers an Rh-positive baby to neutralize fetal Rh-positive red blood cells that may have entered the maternal circulation during delivery. This prevents the mother’s immune system from recognizing the D-antigen and producing its own antibodies (sensitization). Clinical guidelines state that for maximum efficacy, Anti-D should be administered as soon as possible, but **72 hours** is the standard window established to effectively suppress the primary immune response. **2. Why other options are incorrect:** * **4 hours & 24 hours:** While giving the injection earlier is beneficial and recommended, these are not the "outer limit" defined by standard protocols. The 72-hour window is the globally accepted clinical benchmark for postpartum prophylaxis. **3. High-Yield Clinical Pearls for NEET-PG:** * **Standard Dose:** The routine postpartum dose is **300 µg** (1500 IU), which covers a feto-maternal hemorrhage (FMH) of up to 30 mL of fetal whole blood (or 15 mL of packed RBCs). * **Kleihauer-Betke Test:** This test is used to quantify the volume of FMH to determine if additional doses of Anti-D are required. * **Late Administration:** If Anti-D is missed within 72 hours, it should still be given as soon as possible up to **13–28 days** postpartum, as it may still offer some protection, though efficacy decreases. * **Antenatal Prophylaxis:** Standard practice includes a prophylactic dose at **28 weeks** gestation to cover silent FMH during the third trimester. * **Indirect Coombs Test (ICT):** Anti-D is only indicated if the mother is **ICT negative** (unsensitized). If she is already sensitized (ICT positive), Anti-D is of no use.
Explanation: **Explanation:** **Postpartum Hemorrhage (PPH)** is the leading cause of maternal mortality worldwide and in India, accounting for approximately 25–30% of all maternal deaths. The primary medical reason is the rapid blood loss that can occur following delivery; the uterus receives a high volume of blood flow (approx. 600-700 ml/min) at term. If the uterus fails to contract (atony) or if there is significant trauma, a woman can exsanguinate within minutes. **Analysis of Options:** * **Postpartum Hemorrhage (Correct):** It remains the #1 cause globally. **Atonic PPH** is the most common subtype (80% of cases). * **Abortion:** While a significant cause of maternal morbidity and mortality (especially unsafe abortions), it ranks lower than hemorrhage and hypertensive disorders. * **Infection (Sepsis):** Puerperal sepsis is a major cause of death, particularly in settings with poor hygiene, but it is generally the third or fourth leading cause. * **Eclampsia:** Hypertensive disorders of pregnancy (including Pre-eclampsia and Eclampsia) are the second most common cause of maternal mortality globally. **High-Yield Clinical Pearls for NEET-PG:** * **Definition of PPH:** Blood loss >500 ml in vaginal delivery or >1000 ml in Cesarean section. * **Most common cause of PPH:** Uterine Atony (The "4 Ts": Tone, Tissue, Trauma, Thrombin). * **Drug of Choice for Prevention/Treatment:** Oxytocin. * **Active Management of Third Stage of Labor (AMTSL):** The most effective strategy to reduce maternal mortality from PPH. * **Maternal Mortality Ratio (MMR):** Defined as the number of maternal deaths per 100,000 live births.
Explanation: **Explanation:** **Acute puerperal mastitis** is a common postpartum complication, typically occurring 2–4 weeks after delivery. It is characterized by localized breast pain, erythema, and systemic symptoms like fever and malaise. **Why Option C is Correct:** If mastitis is not treated promptly or if the infection is particularly virulent, the inflammation can progress to a localized collection of pus, forming a **breast abscess**. Once a frank abscess develops, antibiotic therapy alone is insufficient; surgical intervention via **Incision and Drainage (I&D)** or ultrasound-guided needle aspiration is mandatory to resolve the infection. **Why Other Options are Incorrect:** * **Option A:** Tetracyclines are contraindicated in breastfeeding mothers as they can cause permanent tooth discoloration and affect bone growth in the infant. The first-line treatment is usually penicillinase-resistant penicillins (e.g., **Dicloxacillin**) or cephalosporins. * **Option B:** The primary source of infection is the **infant’s nasopharynx** or the mother’s skin. Bacteria enter the breast tissue through small cracks or fissures in the nipple. * **Option D:** The most common offending organism is **Staphylococcus aureus** (specifically *Staph. aureus* subsp. *aureus*), not *E. coli*. **High-Yield Clinical Pearls for NEET-PG:** * **Management:** The most important step in managing mastitis is to **continue breastfeeding** or emptying the breast (pumping) to prevent milk stasis, which can worsen the infection. * **Diagnosis:** Mastitis is primarily a clinical diagnosis. If an abscess is suspected but not palpable, **ultrasonography** is the gold-standard imaging modality. * **Bilateral Mastitis:** If mastitis is bilateral, it may rarely suggest a hospital-acquired infection (epidemic mastitis).
Explanation: **Explanation:** The return of menstruation and ovulation in the postpartum period (puerperium) is primarily governed by the levels of serum prolactin. In the absence of breastfeeding, prolactin levels decline rapidly and return to pre-pregnancy levels within **2 to 3 weeks**. **Why 6-8 weeks is correct:** Once prolactin levels drop, the suppression of the hypothalamic-pituitary-ovarian (HPO) axis is lifted. Follicle-stimulating hormone (FSH) levels begin to rise, leading to follicular development. In non-lactating women, the first ovulation occurs at a mean of **45 days** (range 25–72 days). Consequently, the first menstrual bleed typically follows 2 weeks after ovulation, falling within the **6 to 8-week** window. **Analysis of Incorrect Options:** * **A & B (2-6 weeks):** This period is too early for the HPO axis to fully recover and complete a proliferative and secretory cycle. Any bleeding seen before 4 weeks is usually attributed to *lochia alba* or *lochia serosa* rather than true menstruation. * **D (8-10 weeks):** While some women may take longer, the vast majority (over 70%) of non-lactating women will have menstruated by the end of the 8th week. **High-Yield Facts for NEET-PG:** * **First Ovulation:** In non-lactating women, it can occur as early as **25-35 days** postpartum. Therefore, contraception should be started by the 3rd week (Rule of 3). * **Lactational Amenorrhea:** In exclusively breastfeeding women, menstruation is typically delayed for **3 to 6 months** or longer due to prolactin-induced suppression of GnRH pulses. * **Contraception:** Combined Oral Contraceptive Pills (COCPs) are generally avoided in the first 3-6 weeks postpartum due to the increased risk of VTE and interference with milk production (if lactating). Progesterone-only pills (POPs) are the preferred hormonal choice.
Explanation: **Explanation:** The **peripartum period** (specifically the time of labor, delivery, and the immediate 24 hours following birth) is the most critical window for maternal survival. This is because the physiological stress on the maternal cardiovascular and respiratory systems peaks during labor. Most life-threatening complications, such as **Postpartum Hemorrhage (PPH)**—the leading cause of maternal mortality worldwide—and **Amniotic Fluid Embolism**, occur during this narrow timeframe. Additionally, the sudden hemodynamic shifts following placental delivery can trigger heart failure in women with underlying cardiac disease. **Analysis of Options:** * **Antepartum (Option A):** While conditions like pre-eclampsia or antepartum hemorrhage can occur, they are usually managed or stabilized before they become fatal, or they transition into peripartum emergencies. * **Postpartum (Option C):** While the majority of maternal deaths occur in the "extended" postpartum period (up to 42 days), the *intensity* and *concentration* of mortality are highest in the immediate peripartum phase. If "Postpartum" is used broadly, it is a major contributor, but "Peripartum" specifically captures the highest-risk moment of delivery. * **Peripartum (Option B):** This is the correct choice as it encompasses the "danger zone" of active labor and the immediate aftermath where the risk of hemorrhage and eclampsia is at its zenith. **High-Yield Clinical Pearls for NEET-PG:** * **Leading cause of Maternal Mortality (Global & India):** Postpartum Hemorrhage (PPH). * **Most common indirect cause of Maternal Mortality in India:** Anemia (though some recent data suggests Heart Disease is rising in specific cohorts). * **The "Golden Hour":** The first hour after delivery is the most critical for monitoring PPH. * **MMR Definition:** Number of maternal deaths per 1,00,000 live births.
Explanation: **Explanation:** The **Shock Index (SI)** is a clinical tool used to assess hemodynamic stability and occult hemorrhage. It is calculated as the ratio of **Heart Rate (HR) to Systolic Blood Pressure (SBP)**. **1. Why Option D is Correct:** In the context of **Obstetrics**, the normal physiological range for the shock index is **0.7 to 0.9**, but for clinical assessment in postpartum hemorrhage (PPH), a value between **0.9 and 1.1** is often cited as the threshold for identifying significant blood loss. While a non-pregnant adult has a normal SI of 0.5–0.7, the physiological changes of pregnancy (increased heart rate and decreased systemic vascular resistance) shift the baseline higher. An SI of **>0.9** is a sensitive predictor of the need for blood transfusion and surgical intervention in PPH. **2. Why Other Options are Incorrect:** * **Option A (0.3-0.5):** This is abnormally low and rarely seen unless a patient is severely bradycardic or hypertensive. * **Option B (0.5-0.7):** This is the normal range for a **non-pregnant** adult. Using this threshold in pregnancy would lead to over-diagnosis of shock. * **Option C (0.7-0.9):** This is the baseline range for a healthy pregnant woman. It does not indicate the "shock" state associated with significant PPH. **3. High-Yield Clinical Pearls for NEET-PG:** * **Early Warning:** SI is superior to BP or HR alone because BP often remains stable in the early stages of PPH due to compensatory mechanisms. * **Thresholds:** * **SI > 0.9:** Indicates significant blood loss and requires active resuscitation. * **SI > 1.1:** Strongly associated with the need for massive transfusion protocols and intensive care. * **Rule of Thumb:** If the Heart Rate is higher than the Systolic BP (SI > 1.0), the patient is in significant shock until proven otherwise.
Explanation: **Explanation:** The primary mechanism behind **Atonic Postpartum Hemorrhage (PPH)** is the failure of the myometrium to contract effectively after delivery. This prevents the compression of the intramyometrial spiral arteries (the "living ligatures"), leading to excessive bleeding. **Why Erythroblastosis Fetalis is the Correct Answer:** In Erythroblastosis fetalis (Rh isoimmunization), the pathology is characterized by fetal hemolysis, anemia, and **Hydrops Fetalis**. While this leads to an enlarged, edematous placenta (placentomegaly), it does not typically cause overdistension of the uterine musculature itself. Therefore, it is not a classic risk factor for uterine atony. **Analysis of Incorrect Options (Risk Factors for Atony):** * **Multiple Pregnancy & Hydramnios:** Both conditions cause **overdistension of the uterus**. According to Laplace’s law, an overstretched muscle fiber loses its contractile efficiency (similar to a worn-out rubber band), leading to atony after the sudden emptying of the uterus. * **Prolonged Labor:** In prolonged or obstructed labor, the myometrium becomes **exhausted** due to repeated contractions and depletion of glycogen stores, making it unable to contract effectively in the third stage of labor. **NEET-PG Clinical Pearls:** * **Most Common Cause:** Atonic PPH is the most common cause of PPH (approx. 80%). * **The "4 Ts" of PPH:** **T**one (Atony - most common), **T**rauma (Lacerations), **T**issue (Retained products), and **T**hrombin (Coagulopathy). * **Management Gold Standard:** Active Management of the Third Stage of Labor (AMTSL) is the best preventive strategy. * **First-line Drug:** Oxytocin (10 IU IM or 5 IU slow IV). * **Surgical Step:** If medical management fails, the first surgical step is usually **B-Lynch suturing** or uterine artery ligation.
Explanation: **Explanation:** **Carbetocin** is a long-acting synthetic analogue of oxytocin. It is increasingly favored in postpartum care because it has a half-life approximately 4–10 times longer than oxytocin, providing a sustained uterotonic effect with a single dose. **1. Why Option A is Correct:** The standard recommended dose for the prevention of postpartum hemorrhage (PPH) is **100 micrograms**, administered either as a **slow intravenous (IV) injection** over one minute or as an **intramuscular (IM) injection**. In the context of this question, 100 mcg IM is the clinically established dosage and route. It is particularly useful in settings where refrigeration is limited (heat-stable formulations) and where repeated infusions of oxytocin are impractical. **2. Why Other Options are Incorrect:** * **Options B & C:** 50 mcg and 150 mcg are incorrect dosages. Clinical trials and WHO guidelines specifically standardized the dose at 100 mcg to balance efficacy in uterine contraction with a manageable side-effect profile. * **Option D:** 200 mcg is double the recommended dose and increases the risk of adverse effects like hypotension, tachycardia, and nausea without providing additional therapeutic benefit. **3. High-Yield Clinical Pearls for NEET-PG:** * **Mechanism:** Agonist at peripheral oxytocin receptors; causes rhythmic uterine contractions. * **Indication:** Primarily used for the prevention of PPH following Cesarean section or vaginal delivery. * **Advantage over Oxytocin:** Single dose administration; no need for continuous IV infusion. * **Contraindications:** Hypersensitivity to oxytocin/carbetocin, hepatic or renal disease, and serious cardiovascular disorders. * **Storage:** Heat-stable Carbetocin does not require refrigeration (unlike Oxytocin), making it a "Gold Standard" recommendation by the WHO for hot climates.
Explanation: **Explanation:** **Uterine involution** is the physiological process by which the puerperal uterus returns to its pre-pregnant state. Immediately after delivery, the fundus is palpable at the level of the umbilicus (approximately 20 weeks' size). The correct answer is **1.25 cm per day (Option C)**. On average, the uterus descends into the pelvic cavity at a rate of roughly **1 to 1.5 cm per 24 hours**. Standard medical textbooks (such as Williams Obstetrics and DC Dutta) define the average rate as 1.25 cm (or 0.5 inches) per day. By the end of the 2nd week (10–14 days), the uterus becomes a pelvic organ and is no longer palpable abdominally. **Analysis of Incorrect Options:** * **Option A (0.75 cm):** This rate is too slow. A sluggish involution (subinvolution) may indicate retained products of conception or infection (endometritis). * **Option B (1 cm):** While often used as a rough clinical estimate, 1.25 cm is the more precise academic value tested in competitive exams. * **Option D (1.5 cm):** This is the upper limit of the normal range but is not considered the standard average rate for involution. **NEET-PG High-Yield Pearls:** * **Weight Changes:** The uterus weighs ~1000g immediately postpartum, ~500g at 1 week, and ~60g (pre-pregnant weight) by 6 weeks. * **Mechanism:** Involution occurs via **autolysis** (enzymatic breakdown of protein) and ischemia; the number of muscle cells does not decrease, but their size significantly diminishes. * **Clinical Marker:** If the fundus remains high or feels "boggy," suspect **subinvolution**. * **Breastfeeding:** Facilitates faster involution due to endogenous oxytocin release.
Explanation: **Explanation:** Postpartum hemorrhage (PPH) is primarily caused by **uterine atony** (failure of the myometrium to contract effectively after delivery). The correct answer is **Preeclampsia** because it is not a direct cause of atonic PPH; in fact, preeclampsia is more commonly associated with **traumatic PPH** (due to placental abruption) or **coagulopathy**. **Why the other options are causes of Atonic PPH:** * **Fibroid (Option A):** Large intramural or submucous fibroids interfere with the mechanical contraction and "living ligatures" of the uterine muscle fibers, preventing effective compression of intramyometrial blood vessels. * **Multiple Pregnancy (Option B):** This causes **overdistension** of the uterus. Overstretched muscle fibers have poor contractility post-delivery, leading to atony. Other causes of overdistension include polyhydramnios and macrosomia. * **Multiparity (Option C):** Repeated pregnancies lead to the replacement of muscle fibers with fibrous tissue. This reduces the elastic recoil and contractile strength of the myometrium, significantly increasing the risk of atony. **NEET-PG High-Yield Pearls:** * **The "4 Ts" of PPH:** Tone (Atony - 80%), Trauma (Lacerations), Tissue (Retained products), and Thrombin (Coagulopathy). * **Most common cause of PPH:** Uterine Atony. * **Management Gold Standard:** Active Management of Third Stage of Labor (AMTSL) reduces PPH risk by 60%. * **Drug of Choice:** Oxytocin is the first-line agent for both prevention and treatment. * **Preeclampsia Connection:** While not a cause of atony, magnesium sulfate (used to treat eclampsia) is a muscle relaxant and *can* contribute to atony if used in high doses.
Normal Puerperium
Practice Questions
Lactation and Breastfeeding
Practice Questions
Postpartum Complications
Practice Questions
Postpartum Depression and Psychiatric Disorders
Practice Questions
Contraception After Delivery
Practice Questions
Postpartum Infections
Practice Questions
Secondary Postpartum Hemorrhage
Practice Questions
Recovery After Cesarean Delivery
Practice Questions
Postpartum Exercise and Rehabilitation
Practice Questions
Follow-up and Future Pregnancy Planning
Practice Questions
Get full access to all questions, explanations, and performance tracking.
Start For Free